国際学会発表 2022年度
- Ikeda S，Kudo R，Yamashita Y，Kubo T，Mori Y，Harada Y，Shirota H，Hayashi H，Kano M，Shimizu Y，Ishibashi E，Tateishi U，Hirakawa A，Akita H，Matsubara H，Nishihara H，Ishioka C，Aragane N，Muto M，Toyooka S．Primary results from JUPITER, a phase 2 basket trial of combination therapy with trastuzumab and pertuzumab in patients with HER2-amplified solid tumors．2022 ASCO Annual Meeting． In-Person & Online, Chicago．Poster June 3-7（2022）
- Sunami K，Naito Y，Amano T，Ennishi D，Imai M，Kage H，Kanai M，Kenmotsu H，Komine K，Koyama T，Maeda T，Morita S，Saigusa Y，Sakai D，Kinoshita I，Kozuki T，Sakashita H，Kohsaka S，Tsuchihara K，Yoshino T．Impact of learning program on treatment recommendations by molecular tumor boards and an artificial intelligence-based annotation system: A prospective study．2022 ASCO Annual Meeting．In-Person & Online, Chicago．Poster June 3-7（2022）
- Ouchi K，Takahashi S，Osumi H，Otsuki Y，Sasaki K，Shinozaki E，Ishioka C．Prediction of sensitivity to anti-EGFR inhibitors in salvage-line treatment for metastatic colorectal cancer using a modified MethyLight assay．ESMO Congress 2022．Online．Poster Sep 10（2022）
- Ouchi K，Wakayama S，Takahashi S，Yamada Y，Komatsu Y，Shimada K，Yamaguchi T，Shirota H，Takahashi M，Ishioka C．TP53 gain of function mutation as a prognostic factor in high-methylated metastatic colorectal cancer: Translational research of TRICOLORE study．2023 ASCO GI Cancers Symposium．SanFrancisco．Poster Jan 21（2023）
- Yoshinami Y，Osumi H，Takashima A，Sawada R，Ouchi K，Wakatsuki T，Ooki A，Nakayama I，Fukuoka S，Ogura M，Takahari D，Chin K，Hirano H，Shoji H，Okita N，Boku N，Kato K，Ishizuka N，Yamaguchi K，Shinozaki E．A multi-institutional observational study evaluating the incidence and the clinicopathological characteristics of NeoRAS wild-type metastatic colorectal cancer．2023 ASCO GI Cancers Symposium．SanFrancisco．Poster Jan 21(2023)
